2024-05-11 05:05:15
Remegen's Innovative New Drug Telitacicept(RC18) Obtains Positive Phase III Results, Submitted for Second Indication for Treatment of Rheumatoid Arthritis
News/ 2023-09-27
Remegen's Innovative New Drug Telit...

YANTAI,China,Sept. 27,2023-- RemeGen Co.,Ltd.("RemeGen" or "the Company") (HKG: 9995,SHA: 688331),a fully-integrated com...

SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference
News/ 2023-09-27
SK Biopharmaceuticals' Proteovant T...

These are the first in a series of presentations scheduled through the end of the year sharing advances to SK Biopharmaceutical\'s targeted ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release